 Connection
Michael Kahn to p300-CBP Transcription Factors
This is a "connection" page, showing publications Michael Kahn has written about p300-CBP Transcription Factors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.178 |
|
|
|
-
Ono M, Lai KKY, Wu K, Nguyen C, Lin DP, Murali R, Kahn M. Nuclear receptor/Wnt beta-catenin interactions are regulated via differential CBP/p300 coactivator usage. PLoS One. 2018; 13(7):e0200714.
Score: 0.555
-
Zhao Y, Wu K, Nguyen C, Smbatyan G, Melendez E, Higuchi Y, Chen Y, Kahn M. Small molecule p300/catenin antagonist enhances hematopoietic recovery after radiation. PLoS One. 2017; 12(5):e0177245.
Score: 0.511
-
Chan KC, Chan LS, Ip JC, Lo C, Yip TT, Ngan RK, Wong RN, Lo KW, Ng WT, Lee AW, Tsao GS, Kahn M, Lung ML, Mak NK. Therapeutic targeting of CBP/ß-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin. Sci Rep. 2015 Apr 21; 5:9979.
Score: 0.111
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|